| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.09 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |